Expression of Tight Junction Protein Claudin-4 in Basal-Like Breast Carcinomas

详细信息    查看全文

• 作者：Janina Kulka (1)
  Attila Marcell Szász (1)
  Zsuzsanna Németh (1)
  Lilla Madaras (1)
  Zsuzsa Schaff (1)
  István Arthur Molnár (2)
  Anna-Mária T?kés (1)
  
• 关键词：Breast carcinoma ; Basal ; like ; Tissue microarray ; Immunohistochemistry ; Claudin ; 4
• 刊名：Pathology & Oncology Research
• 出版年：2009
• 出版时间：March 2009
• 年：2009
• 卷：15
• 期：1
• 页码：59-64
• 全文大小：265KB
• 参考文献：1. Perou CM, Sorlie T, Eisen MB et al (2000) Molecular portraits of human breast tumours. Nature 406:747-52 CrossRef
  2. Fulford LG, Reis-Filho JS, Ryder K et al (2007) Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival. Breast Cancer Res 9:R4, doi:10.1186/bcr1636 CrossRef
  3. Banerjee S, Reis-Filho JS, Ashley S et al (2006) Basal-like breast carcinomas: clinical outcome and response to chemotherapy. J Clin Pathol 59:729-35 CrossRef
  4. Hu Z, Fan C, Oh DS et al (2006) The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics 7:96 CrossRef
  5. Sorlie T (2007) Molecular classification of breast tumors: toward improved diagnostics and treatments. Methods Mol Biol 360:91-14
  6. Da Silva L, Clarke C, Lakhani SR (2007) Demystifying basal-like breast carcinomas. J Clin Pathol 60:1328-332 CrossRef
  7. Bryan BB, Schnitt SJ, Collins LC (2006) Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer. Mod Path 19:617-21 CrossRef
  8. Buerger H, Otterbach F, Simon R et al (1999) Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes. J Path 189:521-26 CrossRef
  9. Kondoh M (2006) Claudin as a novel target for drug delivery system. Yakugaku Zasshi 126:711-21 CrossRef
  10. Tokes AM, Kulka J, Paku S et al (2005) The expression of five different claudins in invasive breast carcinomas: comparison of pT1pN1 and pT1pN0 tumors. Pathol Res Pract 201:537-44 CrossRef
  11. Tokes AM, Kulka J, Paku S et al (2005) Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res 7:R296–R305 CrossRef
  12. Furuse M, Fujita K, Hiiragi T et al (1998) Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 141:1539-550 CrossRef
  13. Sobel G, Paska C, Szabo I et al (2005) Increased expression of claudins in cervical squamous intraepithelial neoplasia and invasive carcinoma. Human Pathol 36:162-69 CrossRef
  14. Sobel G, Nemeth J, Kiss A et al (2006) Claudin 1 differentiates endometrioid and serous papillary endometrial adenocarcinoma. Gynecol Oncol 103:591-98 CrossRef
  15. Michl P, Barth C, Buchholz M et al (2003) Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. Cancer Res 63:6265-271
  16. Michl P, Buchholz M, Rolke M et al (2001) Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Gastroenterology 121:678-84 CrossRef
  17. Garcia S, Dales JP, Charafe-Jauffret E et al (2007) Poor prognosis in breast carcinomas correlates with increased expression of targetable CD146 and c-Met and with proteomic basal-like phenotype. Human Pathol 38:830-41 CrossRef
  18. Livasy CA, Karaca G, Nanda R et al (2006) Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Path 19:264-71 CrossRef
  
• 作者单位：Janina Kulka (1)
  Attila Marcell Szász (1)
  Zsuzsanna Németh (1)
  Lilla Madaras (1)
  Zsuzsa Schaff (1)
  István Arthur Molnár (2)
  Anna-Mária T?kés (1)
  
  1. 2nd Department of Pathology, Semmelweis University, 93 üll?i út, 1091, Budapest, Hungary
  2. 1st Department of Surgery, Semmelweis University, 78 üll?i út, 1082, Budapest, Hungary
  
• ISSN：1532-2807

文摘

Claudins (CLDN) are tight junction proteins which contribute to the paracellular transport and ionic permeability of various epithelia. In recent years they came into focus for their suggested role in carcinogenesis and possible role in cancer therapy. According to our previous studies, in breast tissue CLDN4 is also related to the level of cellular differentiation. Thirty-eight estrogen (ER) and progesterone receptor (PgR) negative, HER2/neu negative, but cytokeratin 5/6 positive basal-like—mainly grade 3—breast carcinomas were compared with twenty-one grade 1, twenty-five grade 2 and twenty grade 3 non-basal-like invasive breast carcinomas, in respect to their CLDN4 expression. The immunohistochemical reactions were evaluated both semiquantitatively and by morphometrical analysis. Statistically significant difference (p--.001) was observable regarding CLDN4 expression in the basal-like group as compared to grade 1 and 2 cancers. Further, CLDN4 expression was significantly higher (p--.017) in the basal-like compared with the non-basal-like grade 3 carcinomas. Our results suggest that basal-like carcinomas are a subset of breast cancer with high level of CLDN4 protein expression. The finding is in accordance with our former observation that CLDN4 is indeed related to cellular differentiation. This observation may be seen as a further proof that basal-like carcinomas represent a separable group amongst grade 3 breast carcinomas.